1 min read Anxiety & Stress 1: SSL 1 min read Mental health is not a destination, but a process
Insurance coverage for GLPs vary widely, with some covering it for weight loss and others barely covering it for diabetes and only certain types
Whether you're seeking more energy or a stronger foundation for long-term wellness, this guide could be a game changer
Subgroup analyses revealed important differences based on comparator drugs: GLP-1RAs demonstrated greater effectiveness than SGLT2 inhibitors in preventing MALOs (IRR: 0.93, 95%CI: 0.87-0.99, P = 0.043), than DPP-4 inhibitors in preventing hepatic decompensation events (IRR: 0.74, 95%CI: 0.66-0.83, P = 0.003), and than insulin therapy in averting HCC development (IRR: 0.32, 95%CI: 0.13-0.80, P = 0.033) [64]
Growing Awareness and Acceptance of New Therapies: There is an increasing awareness and acceptance of new therapies, including GLP-1 receptor agonists, among healthcare practitioners and patients
Beyond targeting blood sugar stabilization, GLp 1 agonists also stand out as potent agents against obesity due to associated weight reduction benefits stemming from enhanced feelings of satiety and slowed digestive processes resulting naturally into lesser caloric intake
